EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2018
Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2018
(Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Charenton-le-Pont, France (January 10, 2019 - 6:00 pm) As of December 31, 2018, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated below.
| December 31, 2018 | |
| Shares outstanding | 426,777,218 |
| Number of real voting rights (excluding treasury shares) | 425,677,461 |
| Theoretical number of voting rights (including treasury shares) | 426,777,218 |
It is to be noted that voting rights are capped at 31% in accordance with a formula contained in EssilorLuxottica's by-laws. For illustrative purposes, during the last Ordinary and Extraordinary General Meeting of the Company that took place on November 29, 2018, Delfin S.à r.l. was holding 38.85% of the share capital of the Company and, by application of such formula contained in the by-laws, its exercisable voting rights during such General Meeting were capped at 32.59%. After taking into consideration such cap and the treasury shares, the total number of voting rights effectively exercisable during such General Meeting was 324,261,424.
For further information, please consult the Prospectus which received Visa No. 18-460 from the AMF on September 28, 2018 and its Securities Note Supplement which received Visa No. 18-494 from the AMF on October 23, 2018, available on the website www.essilor-luxottica.com
CONTACTS
| EssilorLuxottica Investor Relations (Charenton-le-Pont) Tel: + 33 1 49 77 42 16 (Milan) Tel: + 39 (02) 8633 4870 E-mail: ir@essilor-luxottica.com |
EssilorLuxottica Corporate Communications (Charenton-le-Pont) Tel: + 33 1 49 77 45 02 (Milan) Tel: + 39 (02) 8633 4470 E-mail: media@essilor-luxottica.com |
Attachment
Latest Health & Supplement Reviews
- YuSleep Reviews (EXPOSED) Doctor Explains Deep Sleep Benefits, Hidden Risks & Real Consumers Results In 2026
- Neuro Energizer Reviews and Complaints 2026: How This Neuro-Sonic Breakthrough Is Reshaping Cognitive Therapy, Memory & Daily Focus
- Gluco6 Reviews and Complaints (March 2026) Real User Data on Natural Blood Sugar Balance and Glucose Stability